06/09/2008-
The Federal Motor Carrier Safety Administration has advised medical examiners not to certify drivers taking Chantix, a popular smoking-cessation drug, because it may adversely affect driving.
FMCSA Administrator John Hill issued an advisory on Chantix, also known by the generic term varenicline, after the U.S. Food and Drug Administration released its own advisory on the drug. The FDA had cautioned against driving or operating machinery until the patient knows how Chantix affects him.
FMCSA medical regulations for interstate truck and bus drivers prohibit the use of prescribed drugs that adversely affect the driver's ability to safely operate a commercial motor vehicle.
The Federal Aviation Administration ordered pilots and air traffic controllers to stop taking it immediately after a medical safety group, the Institute for Safe Medication Practices, released the results of a study in late May that found evidence of seizures, loss of consciousness, heart attacks, vision problems and psychiatric instabilities in individuals who use Chantix.
If you are currently taking Chantix and have concerns about its safety, you should consult with your doctor regarding your treatment options. Under no circumstances should you discontinue taking any medication, including Chantix, without first consulting with your doctor. For Chantix legal information contact the Chantix Attorneys of Ennis & Ennis, P.A. by filling out our free Chantix case evaluation form or by calling the toll-free number listed below.
